Abstract: This communication reports a practical synthesis of conjugate (1), which combines a netropsin analog and a 2,5-diaziridinylquinone moiety. Following continuous exposure, compound 1 was cytotoxic against the growth of human cancer cells in culture, with IC 50 values in the range of 0.13 μΜ to 0.01 μΜ. It, however, displayed little differential cytotoxicity against cancer cells rich in DT-diaphorase [human lung cancer H460] and cells without the functional enzyme [human colon cancer BE], DNA interactive agents belong to an important part of the chemotherapeutic arsenal for the treatment of cancer.' However, such cancer chemotherapeutic agents generally suffer from severe toxicity to the hosts, because they destroy both cancer and normal cells.
Introduction
The focus of this project centers on taking advantage of the general hypoxic nature of solid tumors. In current developments of DNA interactive anticancer drugs, the minor groove has emerged as an attractive to inhibit the growth of cancer cells with or without DT-diaphorase will be studied.
The synthetic strategy for the preparation of target conjugate 1 is outlined in Scheme 1. Beginning with the dipyrrole carboxylic acid intermediate 2," that our group had previously reported, it was coupled with N-BOC protected 1,3-diaminopropane in the presence of dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole (HOBt) to give product 3 in 80 percent yield. Removal of the BOC protecting group by 3M hydrochloric acid, followed by a base work up gave the free primary amine 4 in 15 percent yield, after purification on a silica gel column. The low yield in this reaction was presumably due to acid hydrolysis of the amido groups in 136, which is a dimer of two pyrrolobenzodiazepine units; 9 and tallimustine, a conjugate of distamycin with a benzoic acid mustard. 
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Results and Discussion
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Heterocyclic Communications compound 3, and decomposition of the resulting pyrrole-amines as indicated by the formation of highly polar and colored materials. Amine 4 was coupled to a quinone carboxylic acid 5 12 in presence of DCC and HOBt to give compound 6 in 44 percent yield. The aziridinyl groups in conjugate 1 were introduced by reaction of compound 6 with aziridine, and the desired burgundy-colored solid product 1 was isolated in 40 percent yield after silica gel column chromatography. The structure of conjugate 1 and the intermediates were characterized by 500 MHz NMR, FT-IR, FABmass spectrometry and accurate mass measurements. Since aziridines tend to be reactive with nucleophiles, conjugate 1 was stored solvent-free and under an atmosphere of nitrogen in a dessicator that was kept inside a freezer.
The cytotoxicity studies were done using a MTT assay, and the cells were continuously treated with the compound for 5 days. 13 Two different human cancer cell lines were used for these studies. H460 is a human lung cancer cell line is rich in DT-diaphorase, but BE cells, that is derived from a human colon cancer, lack this bioreductive enzyme. 4 The results from the cytotoxicity studies, expressed as IC 50 concentrations in M, are given in Table 1 . For H460 cells, compound 1 was found to have comparable cytotoxic potency as RH1. However, unlike RH1 as indicated by the high selectivity index for H460 cells, compound 1 did not give a significant differential cytotoxicity against H460 cells over BE cells, indicating that DT-diaphorase promoted reduction is not required for conjugate 1 to exert its biological effect. It is possible that compound 1 and RH1 have different mechanisms activation, and studies to determine the mechanism of action of conjugate 1 is in progress. 
